1.A Case of Intrauterine Thyroxine Therapy for Fetal Goitrous Hypothyroidsm.
Mi Young LEE ; Hye Sung WON ; Eu Gene KIM ; Jeong Min EOM ; Jei Won MOON ; Ree Mi YOU ; Pil Ryang LEE ; Ahm KIM
Korean Journal of Perinatology 2009;20(2):158-162
A 28-year-old primi gravida visited our department at 20 weeks gestation. The ultrasound screening revealed twin gestation, and follow up screening revealed a bilobed large fetal neck mass in the 1st twin. We measured thyroid volume with ultrasound which was 5.072 cm3. Other fetal organs appeared normal. Cordocentesis was performed for fetal thyroid function and congenital hypothyroidism was confirmed. In addition, maternal thyroid hormones were checked. The other fetus was normal. Thyroid stimulating hormone (TSH) in the maternal serum was increased, but thyroxine (T3) was (within normal range). Two weeks later, we checked TSH and free T4 in amniotic fluid and administered intra-amniotic thyroxine (200 ?g). We repeated the procedures 2 more times in two consecutive weeks. After 3 intra-amniotic thyroxine injection, follow-up cordocentesis revealed euthyroid status of the fetus. Although the thyroid gland had decreased in size and volume, it was still goitrous. At 36 weeks of gestation, the patient was admitted for preterm premature rupture of the membranes and the twin was delivered vaginally. The 1st twin was proved as an euthyroid status and antithyroid antibody was not detected. During the 3 years follow up, the baby had no considerable developmental problem. The intrauterine recognition and treatment of congenital goitrous hypothyroidism may not only reduce the obstetric complications associated with large goiters, but possibly improve the prognosis for normal growth and mental development of affected fetuses.
Adult
;
Amniotic Fluid
;
Congenital Hypothyroidism
;
Cordocentesis
;
Female
;
Fetal Membranes, Premature Rupture
;
Fetus
;
Follow-Up Studies
;
Goiter
;
Humans
;
Hypothyroidism
;
Mass Screening
;
Membranes
;
Neck
;
Pregnancy
;
Prognosis
;
Rupture
;
Thyroid Gland
;
Thyroid Hormones
;
Thyrotropin
;
Thyroxine
;
Twins
2.The Developmental Outcome of Fetal Mild Isolated Ventriculomegaly.
Myung Sook JEONG ; Jung Mi CHUN ; Kyung Ah KIM ; Sun Young KO ; Yeon Kyung LEE ; Son Moon SHIN ; Eu Ree LEE
Korean Journal of Pediatrics 2005;48(8):826-831
PURPOSE: This study is directed to evaluate standardized developmental test performances of infants and children who, as fetuses, had mild isolated cerebral ventriculomegaly diagnosed by ultrasound. METHODS: All prenatal sonographic findings from 2001 to 2002 were evaluated. Live isolated mild ventriculomegaly (IMVM) of 10-15 mm were observed in 95 cases (1.1 percent). Standardized developmental testing of 40 cases of IMVM and 36 cases in a comparison group were offered to parents Both groups of children were adjusted to normal antepatum subjects with respect to sex, race, indication for ultrasound and gestational age at the time of ultrasound. Test of cognitive and motor development (Bayley Scales of Infant Development, Second Edition; BSID-II) were administered by developmental examiners. RESULTS: Forty cases and 34 comparison sujects completed the testing. The IMVM and comparison groups were similar with respect to parental age, gestational age, birth weight, familial socioeconomic status. The IMVM subjects scored lower than the comparison group on both the BSID-II, but there was not statistically significant. differences; metal development index (MDI) (92.7+/-12.9 vs 94.7+/-14.1, P=0.47) and psychomotor development index (PDI) (100.3+/-14.1 vs 101.3+/-10.7, P=0.75). Eleven cases (27.5 percent) of IMVM group and five cases (14.7 percent) of the comparison group were developmentally delayed, but most cases in both groups showed mild delays. Resolution or lack of progression, lateral ventricle diameter < or= 12 mm and females were associated with better scores, but there were not statistically significant. Polarity, and head circumference were not related to later development. CONCLUSION: This study show children with MIVM did not delay performance in the developmental test, but we might suggest a tendency to increase the risk of mild developmental delay.
Birth Weight
;
Child
;
Child Development
;
Continental Population Groups
;
Female
;
Fetus
;
Gestational Age
;
Head
;
Humans
;
Hydrocephalus
;
Infant
;
Lateral Ventricles
;
Parents
;
Social Class
;
Ultrasonography
;
Weights and Measures
3.Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea.
Won Suk CHOI ; Cheol In KANG ; Yonjae KIM ; Jae Phil CHOI ; Joon Sung JOH ; Hyoung Shik SHIN ; Gayeon KIM ; Kyong Ran PECK ; Doo Ryeon CHUNG ; Hye Ok KIM ; Sook Hee SONG ; Yang Ree KIM ; Kyung Mok SOHN ; Younghee JUNG ; Ji Hwan BANG ; Nam Joong KIM ; Kkot Sil LEE ; Hye Won JEONG ; Ji Young RHEE ; Eu Suk KIM ; Heungjeong WOO ; Won Sup OH ; Kyungmin HUH ; Young Hyun LEE ; Joon Young SONG ; Jacob LEE ; Chang Seop LEE ; Baek Nam KIM ; Young Hwa CHOI ; Su Jin JEONG ; Jin Soo LEE ; Ji Hyun YOON ; Yu Mi WI ; Mi Kyong JOUNG ; Seong Yeon PARK ; Sun Hee LEE ; Sook In JUNG ; Shin Woo KIM ; Jae Hoon LEE ; Hyuck LEE ; Hyun Kyun KI ; Yeon Sook KIM
Infection and Chemotherapy 2016;48(2):118-126
BACKGROUND: From May to July 2015, the Republic of Korea experienced the largest outbreak of Middle East respiratory syndrome (MERS) outside the Arabian Peninsula. A total of 186 patients, including 36 deaths, had been diagnosed with MERS-coronavirus (MERS-CoV) infection as of September 30th, 2015. MATERIALS AND METHODS: We obtained information of patients who were confirmed to have MERS-CoV infection. MERS-CoV infection was diagnosed using real-time reverse-transcriptase polymerase chain reaction assay. RESULTS: The median age of the patients was 55 years (range, 16 to 86). A total of 55.4% of the patients had one or more coexisting medical conditions. The most common symptom was fever (95.2%). At admission, leukopenia (42.6%), thrombocytopenia (46.6%), and elevation of aspartate aminotransferase (42.7%) were observed. Pneumonia was detected in 68.3% of patients at admission and developed in 80.8% during the disease course. Antiviral agents were used for 74.7% of patients. Mechanical ventilation, extracorporeal membrane oxygenation, and convalescent serum were employed for 24.5%, 7.1%, and 3.8% of patients, respectively. Older age, presence of coexisting medical conditions including diabetes or chronic lung disease, presence of dyspnea, hypotension, and leukocytosis at admission, and the use of mechanical ventilation were revealed to be independent predictors of death. CONCLUSION: The clinical features of MERS-CoV infection in the Republic of Korea were similar to those of previous outbreaks in the Middle East. However, the overall mortality rate (20.4%) was lower than that in previous reports. Enhanced surveillance and active management of patients during the outbreak may have resulted in improved outcomes.
Antiviral Agents
;
Aspartate Aminotransferases
;
Coronavirus Infections*
;
Disease Outbreaks
;
Dyspnea
;
Extracorporeal Membrane Oxygenation
;
Fever
;
Humans
;
Hypotension
;
Leukocytosis
;
Leukopenia
;
Lung Diseases
;
Middle East Respiratory Syndrome Coronavirus
;
Middle East*
;
Mortality
;
Pneumonia
;
Polymerase Chain Reaction
;
Republic of Korea*
;
Respiration, Artificial
;
Thrombocytopenia